Your browser doesn't support javascript.
loading
Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG).
Rücker, Frank G; Corbacioglu, Andrea; Krzykalla, Julia; Cocciardi, Sibylle; Lengerke, Claudia; Germing, Ulrich; Wulf, Gerald; Samra, Maisun A; Teichmann, Lino L; Lübbert, Michael; Kühn, Michael W M; Bentz, Martin; Westermann, Jörg; Bullinger, Lars; Gaidzik, Verena I; Meid, Annika; Aicher, Sophia; Stegelmann, Frank; Weber, Daniela; Schrade, Anika; Thol, Felicitas; Heuser, Michael; Ganser, Arnold; Benner, Axel; Döhner, Hartmut; Döhner, Konstanze.
Afiliação
  • Rücker FG; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Corbacioglu A; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Krzykalla J; Division of Biostatistics German Cancer Research Center Heidelberg Germany.
  • Cocciardi S; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Lengerke C; Medical Clinic, Department of Hematology, Oncology, Clinical Immunology and Rheumatology University Hospital Tübingen Tübingen Germany.
  • Germing U; Department of Hematology, Oncology and Clinical Immunology Heinrich Heine University Düsseldorf Germany.
  • Wulf G; Department of Hematology and Medical Oncology University Medical Center Göttingen Göttingen Germany.
  • Samra MA; Department of Internal Medicine IV University Hospital of Gießen Gießen Germany.
  • Teichmann LL; Department of Medicine and Polyclinic III Bonn University Hospital Bonn Germany.
  • Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation University of Freiburg Medical Center Freiburg Germany.
  • Kühn MWM; Department of Hematology and Oncology University Medical Center Mainz Mainz Germany.
  • Bentz M; Department of Internal Medicine III Hospital of Karlsruhe Karlsruhe Germany.
  • Westermann J; Department of Hematology, Oncology and Tumor Immunology Charité University Medicine Berlin Germany.
  • Bullinger L; Department of Hematology, Oncology and Tumor Immunology Charité University Medicine Berlin Germany.
  • Gaidzik VI; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Meid A; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Aicher S; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Stegelmann F; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Weber D; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Schrade A; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Thol F; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany.
  • Heuser M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany.
  • Ganser A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School Hannover Germany.
  • Benner A; Division of Biostatistics German Cancer Research Center Heidelberg Germany.
  • Döhner H; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
  • Döhner K; Department of Internal Medicine III University Hospital of Ulm Ulm Germany.
Hemasphere ; 8(7): e123, 2024 Jul.
Article em En | MEDLINE | ID: mdl-39011127
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hemasphere Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hemasphere Ano de publicação: 2024 Tipo de documento: Article